-
My Account
My Account
BSE Live
Mar 05, 16:00Prev. Close
6700.05
Open Price
6748.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 05, 15:58Prev. Close
6699.45
Open Price
6700.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Procter & Gamble Health (in Rs. Cr.) | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 | |
| Net Sales/Income from operations | 926.60 | 849.00 | 1,103.96 | 968.34 | 908.33 | |
| Other Operating Income | -- | -- | -- | 28.00 | 31.17 | |
| Total Income From Operations | 926.60 | 849.00 | 1,103.96 | 996.33 | 939.50 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 298.49 | 245.52 | 236.56 | 240.24 | 256.93 | |
| Purchase of Traded Goods | 18.90 | 27.31 | 201.61 | 173.08 | 179.94 | |
| Increase/Decrease in Stocks | -17.51 | -3.47 | 2.90 | -0.69 | -1.62 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 124.21 | 131.28 | 169.64 | 148.67 | 123.39 | |
| Depreciation | 17.17 | 21.12 | 26.40 | 27.55 | 23.42 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 298.94 | 300.21 | 355.62 | 321.50 | 297.42 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 186.42 | 127.03 | 111.22 | 85.98 | 60.03 | |
| Other Income | 47.94 | 24.39 | 23.97 | 24.24 | 23.30 | |
| P/L Before Int., Excpt. Items & Tax | 234.36 | 151.42 | 135.19 | 110.22 | 83.33 | |
| Interest | -- | -- | -- | -- | -- | |
| P/L Before Exceptional Items & Tax | 234.36 | 151.42 | 135.19 | 110.22 | 83.33 | |
| Exceptional Items | -- | 6.57 | 17.00 | -- | -- | |
| P/L Before Tax | 234.36 | 157.98 | 152.19 | 110.22 | 83.33 | |
| Tax | 75.60 | 56.24 | 58.28 | 34.33 | 29.77 | |
| P/L After Tax from Ordinary Activities | 158.76 | 101.74 | 93.91 | 75.89 | 53.56 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | 736.98 | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 158.76 | 838.72 | 93.91 | 75.89 | 53.56 | |
| Equity Share Capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
| Reserves Excluding Revaluation Reserves | 800.22 | 1,523.51 | 716.66 | 628.86 | 574.95 | |
| Equity Dividend Rate (%) | 2,300.00 | 4,400.00 | 150.00 | 110.00 | 75.00 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 95.64 | 505.27 | 56.57 | 45.72 | 32.27 | |
| Diluted EPS | 95.64 | 505.27 | 56.57 | 45.72 | 32.27 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 95.64 | 505.27 | 56.57 | 45.72 | 32.27 | |
| Diluted EPS. | 95.64 | 505.27 | 56.57 | 45.72 | 32.27 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
25.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
23.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
11.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
15.12.2020
Procter&Gamble Standalone September 2020 Net Sales at Rs 263.97 crore, up 17.23% Y-o-Y
